Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 5/20 | 0.83 |
| ▸ | HSD17B10 | Q99714 | 5/20 | 0.83 |
| ▸ | ESR1 | P03372 | 5/20 | 0.77 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.77 |
| ▸ | PGR | P06401 | 2/20 | 0.77 |
| ▸ | AR | P10275 | 2/20 | 0.77 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.77 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.77 |
| ▸ | ATM | Q13315 | 2/20 | 0.77 |
| ▸ | ABCC1 | P33527 | 1/20 | 0.77 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.77 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.77 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.77 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.77 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.77 |
| ▸ | STS | P08842 | 2/20 | 0.75 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.75 |
| ▸ | TSHR | P16473 | 2/20 | 0.74 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.74 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.74 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5078078 | 1.00 | LMNA (0.83) | LMNAHSD17B10ESR1SMN1; SMN2PGR | |
| SCHEMBL980768 | 0.92 | LMNA (0.85) | LMNAHSD17B10ESR1SMN1; SMN2PGR | |
| Estradiol Methyl Ether SCHEMBL9558220 | 0.91 | HSD17B10 (1.00) | LMNAHSD17B10ESR1SMN1; SMN2PGR | |
| Estradiol Methyl Ether SCHEMBL547265 | 0.91 | HSD17B10 (1.00) | LMNAHSD17B10ESR1SMN1; SMN2PGR | |
| Estradiol Methyl Ether SCHEMBL8998255 | 0.91 | HSD17B10 (1.00) | LMNAHSD17B10ESR1SMN1; SMN2PGR | |
| Estradiol Methyl Ether SCHEMBL23645792 | 0.91 | HSD17B10 (1.00) | LMNAHSD17B10ESR1SMN1; SMN2PGR | |
| Estradiol Methyl Ether SCHEMBL18686406 | 0.91 | HSD17B10 (1.00) | LMNAHSD17B10ESR1SMN1; SMN2PGR | |
| Estradiol Methyl Ether SCHEMBL6464173 | 0.91 | HSD17B10 (1.00) | LMNAHSD17B10ESR1SMN1; SMN2PGR | |
| Estradiol Methyl Ether SCHEMBL4750578 | 0.91 | HSD17B10 (1.00) | LMNAHSD17B10ESR1SMN1; SMN2PGR | |
| Estradiol Methyl Ether SCHEMBL14499084 | 0.91 | HSD17B10 (1.00) | LMNAHSD17B10ESR1SMN1; SMN2PGR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 95 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022082183-A1 | COMPOUNDS AND METHODS FOR THE TREATMENT OF INFLAMMATORY AND METABOLIC DISEASES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2022-04-21 | — | — | WO | claimed |
| WO-2022074001-A1 | MEANS AND METHODS FOR THE CONVERSION OF ESTRADIOL TO 15ALPHA-HYDROXYESTRADIOL | MITHRA RECHERCHE ET DÉVELOPPEMENT SA (BE) | 2022-04-14 | — | — | WO | claimed |
| WO-2008065408-A9 | MODULATION OF PROSTAGLANDIN/CYCLOOXYGENASE METABOLIC PATHWAYS | HUNTER-FLEMING LIMITED (GB) | 2011-03-03 | — | — | WO | claimed |
| WO-2010096830-A2 | METHOD TO TREAT PSORIASIS AND OTHER HYPERPROLIFERATIVE SKIN DISORDERS | CORNELL UNIVERSITY (US) | 2010-08-26 | — | — | WO | claimed |
| WO-2008147640-A2 | HORMONE REPLACEMENT THERAPY | UNIVERSITY OF KANSAS MEDICAL CENTER (US) | 2008-12-04 | — | — | WO | claimed |
| EP-1507514-B1 | CONTROLLED RELEASE COMPOSITIONS OF ESTRADIOL METABOLITES | PR PHARMACEUTICALS INC (US) | 2007-02-14 | — | — | EP | claimed |
| EP-1594481-A4 | MONOUNSATURATED FATTY ACIDS AND PERHYDROCYCLOPENTANOPHENANTHRENE NUCLEUS COMBINATION MOLECULES, AND THEIR PRECURSORS, AND THE USE OF ALL OF THESE AS WEIGHT-LOSS AGENTS | GIROUARD MICHAEL P (US) | 2006-05-17 | — | — | EP | claimed |
| EP-1594481-A2 | MONOUNSATURATED FATTY ACIDS AND PERHYDROCYCLOPENTANOPHENANTHRENE NUCLEUS COMBINATION MOLECULES, AND THEIR PRECURSORS, AND THE USE OF ALL OF THESE AS WEIGHT-LOSS AGENTS | Girouard, Michael P. (US) | 2005-11-16 | — | — | EP | claimed |
| US-20040157816-A1 | Monounsaturated fatty acids and perhydrocyclopentanophenanthrene nucleus combination molecules, and their precursors, and the use of all of these as weight-loss agents | GIROUARD MICHAEL P (US) | 2004-08-12 | — | — | US | claimed |
| WO-2004045560-A2 | COMBINATION OF MONOUNSATURATED FATTY ACIDS AND ESTOGEN, AND THEIR USE | GIROUARD MICHAEL P (US) | 2004-06-03 | — | — | WO | claimed |
| JP-2000511404-A | — | — | 2000-09-05 | — | — | JP | claimed |
| EP-0954317-A2 | USE OF 7 APHA-SUBSTITUTED STEROIDS TO TREAT NEUROPSYCHIATRIC, IMMUNE OR ENDOCRINE DISORDERS | BTG INTERNATIONAL LIMITED (GB) | 1999-11-10 | — | — | EP | claimed |
| EP-0874642-A1 | SUSTAINED RELEASE DRUG FORMULATIONS | DELAB (FR) | 1998-11-04 | — | — | EP | claimed |
| WO-1997037664-A2 | USE OF 7 ALPHA-SUBSTITUTED STEROIDS TO TREAT NEUROPSYCHIATRIC, IMMUNE OR ENDOCRINE DISORDERS | BRITISH TECHNOLOGY GROUP LTD. (GB) | 1997-10-16 | — | — | WO | claimed |
| WO-1997026015-A1 | SUSTAINED RELEASE DRUG FORMULATIONS | DELAB (FR) | 1997-07-24 | — | — | WO | claimed |
| US-4427669-A | 2-HYDROXY-OR 4-HYDROXYESTRADIOL | THE BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA (US) | 1984-01-24 | — | — | US | claimed |
| US-4011314-A | FOR TREATING ESTROGEN DEFICIENCY | SCHERING AKTIENGESELLSCHAFT (DT) | 1977-03-08 | — | — | US | claimed |
| JP-63166898-A | — | — | None | — | — | JP | disclosed |
| JP-S6445392-A | PRODUCTION OF ESTRADIOL DERIVATIVE | TOA NENRYO KOGYO KK | 1989-02-17 | — | — | JP | disclosed |
| JP-S63166898-A | SEPARATION AND DETERMINATION OF STEROID | TOSOH CORP | 1988-07-11 | — | — | JP | disclosed |